Breast Cancer Surgery Timing and Cell Growth
Author Information
Author(s): LS Cooper, CE Gillett, P Smith, IS Fentiman, DM Barnes
Primary Institution: Imperial Cancer Research Fund Clinical Oncology Unit
Hypothesis
Does the timing of surgery during the menstrual cycle affect the prognosis of premenopausal women with breast cancer?
Conclusion
The timing of surgery and the level of cell proliferation are significant predictors of survival in premenopausal women with breast cancer.
Supporting Evidence
- Women with slowly proliferating tumors removed in the luteal phase had a very good prognosis.
- Patients operated on during the follicular phase had a poorer outcome compared to those operated on during the luteal phase.
- MIB1 score was significantly associated with overall survival.
Takeaway
This study found that when women have breast cancer surgery during certain times of their menstrual cycle, it can affect how long they live after treatment.
Methodology
The study compared MIB1 staining of tumor samples with flow cytometry to assess cell proliferation and analyzed survival data based on the timing of surgery during the menstrual cycle.
Limitations
The study was limited to a subset of patients and may not be generalizable to all breast cancer patients.
Participant Demographics
All participants were premenopausal women diagnosed with primary infiltrating mammary carcinoma.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website